NCT01290133View on ClinicalTrials.gov

Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Post-Operative Nausea and Vomiting (PONV)
Interventions
DRUG

GW597599

Single dose IV infusion

DRUG

Placebo

Single dose IV infusion

Trial Locations (1)

Unknown

Investigational Site, Melbourne

Sponsors

Lead Sponsor

Accenture
All Listed Sponsors
lead

Accenture

INDUSTRY